Antigen Recognition by Lymphocytes

淋巴细胞识别抗原

基本信息

  • 批准号:
    7846521
  • 负责人:
  • 金额:
    $ 2.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-05 至 2010-09-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The specificities and numbers of lymphocytes in animals are tightly controlled to avoid autoimmunity and to avoid accumulation of lymphocytes generated during previous infections. This control can be achieved through the death of autoreactive lymphocytes as consequence of selection events. Similarly, many lymphocytes that are generated in response to infections die when the infectious agent disappears. The lymphocyte repertoire is also influenced by the ability of lymphocytes to alter their antigen receptor. For example, the antigen receptor expressed by some autoreactive lymphocytes can be modified either by deletion of the genes encoding the offending receptor, or by silencing the action of the autoreactive receptor. The numbers, specificities and activities of lymphocytes in animals are controlled, to avoid accumulation of the huge numbers of lymphocytes which are generated in each successive response to infection and to prevent autoimmunity. Several processes are used to achieve this control. Many of the lymphocytes which are generated in response to infections die when the infectious agent disappears. Some autoreactive lymphocytes die, others modify their receptors for antigen, either by deleting genes coding for the offending receptor, or by somehow silencing the action of the autoreactive receptor. Other autoreactive lymphocytes survive for a while as anergic cells and do not respond productively to antigen and have a shortened half life. The Projects in this Program will examine the ways in which lymphocytes are controlled, comparing the mechanisms used in different types of lymphocytes under different circumstances, with the goal of understanding how the immune system generates a useful but innocuous collection of antigen specific lymphocytes. The individual Projects will focus as follows: 1. On the role of bystander, non autoreactive receptors on B cells, and their ability to rescue cells bearing, in addition, autoreactive receptors from death. 2. On the generation and maintenance of anergic B cells, their specificities and the ability of infectious agents to allow these cells to escape anergy. 3. On the role of Bcl-2 related proteins in the death of activated T, and B cells. The Program has 4 Cores, all essential to the work on all Projects. The subjects of the Cores are: Flow Cytometry; Microscopy; Genetics and Administration. PROJECT 1: Mechanisms of B Cell Survival and Death (Pelanda, R.) PROJECT 1 DESCRIPTION (provided by applicant): Millions of B cells are generated daily that express autoreactive antibodies. Recent studies in mice indicate that newly generated immature B cells that react with autoantigens in the bone marrow undergo receptor editing and anergy, and that receptor editing contributes to a significant fraction of the peripheral protective antibody repertoire. These recent studies also suggest that clonal deletion, once thought the predominant mechanism of central tolerance, is probably a default pathway that is carried out when autoreactive B cells are unable to edit their receptors. It is intrinsic to this model that autoreactive B cells must survive for a certain amount of time in order to successfully edit their receptors. Differences in cell survival of autoreactive and non-autoreactive immature B cells ultimately control the selection of these cells and shape the peripheral B cell repertoire. Therefore, we propose that the window of survival of autoreactive immature B cells during which receptor editing takes place is absolutely essential for the development of a protective peripheral antibody repertoire. What physiologically controls the lifespan of immature B cells during receptor editing is not yet clear although likely involves the regulated activity of anti- and pro-apoptotic pathways. In addition to receptor editing, the generation of a specific, effective and innocuous B cell repertoire also relies on the signals that stop further Ig gene rearrangement upon expression of nonautoreactive BCRs and mediate immunoglobulin allelic/isotypic exclusion. Dysfunctions in these pathways may cause either excessive clonal deletion resulting in immunodeficiency or survival of autoreactive B cells resulting in autoimmunity. Available evidences indicate that the expression of non-autoreactive B cell antigen receptors generates tonic signals that are important for survival of non-autoreactive (primary and edited and possibly anergic) immature B cells as well as immunoglobulin allelic/isotypic exclusion. We propose that the NF-?B pathway, BAFF-R signaling and the Bcl-2 family properly translate B cell antigen receptor signaling to regulate cellular lifespan and immunoglobulin gene recombination. We have created mouse strains that generate either nonautoreactive or autoreactive immature B cells, and other strains that have abnormal levels of BCR and BAFF-R expression. Using these biological tools, we propose to determine how the NF-?B pathway and the Bcl-2 family regulate the lifespan of primary immature B cells, and what is the relative contribution of BCR and BAFF-R signaling to cell survival and establishment of Ig allelic/isotypic exclusion. This project will contribute to our understanding of what regulates the lifespan of developing B cells, in particular depending on whether the cells are autoreactive or not. Moreover, our findings will indicate possible mechanisms by which autoreactive B cells escape tolerance and eventually differentiate into autoantibody-forming cells.
性状(由申请方提供):严格控制动物中淋巴细胞的特异性和数量,以避免自身免疫和避免既往感染期间产生的淋巴细胞蓄积。这种控制可以通过选择事件导致自身反应性淋巴细胞死亡来实现。类似地,许多因感染而产生的淋巴细胞在感染因子消失时死亡。淋巴细胞库也受到淋巴细胞改变其抗原受体的能力的影响。例如,由一些自身反应性淋巴细胞表达的抗原受体可以通过缺失编码攻击性受体的基因或通过沉默自身反应性受体的作用来修饰。 控制动物中淋巴细胞的数量、特异性和活性,以避免在对感染的每次连续反应中产生的大量淋巴细胞的积累,并防止自身免疫。几个过程被用来实现这种控制。当感染原消失时,许多因感染而产生的淋巴细胞就会死亡。一些自身反应性淋巴细胞死亡,另一些则通过删除编码攻击性受体的基因或以某种方式沉默自身反应性受体的作用来修改其抗原受体。其他自身反应性淋巴细胞作为无反应性细胞存活一段时间,对抗原不产生有效反应,半衰期缩短。 该计划中的项目将研究淋巴细胞的控制方式,比较不同情况下不同类型淋巴细胞的机制,目的是了解免疫系统如何产生有用但无害的抗原特异性淋巴细胞。各个项目的重点如下: 1.旁观者的作用,B细胞上的非自身反应性受体,以及它们拯救携带自身反应性受体的细胞免于死亡的能力。 2.关于无反应性B细胞的产生和维持,它们的特异性和感染因子使这些细胞逃避无反应性的能力。 3. Bcl-2相关蛋白在活化T、B细胞死亡中的作用 该计划有4个核心,对所有项目的工作都至关重要。核心的主题是:流动 细胞计数;显微镜检查;遗传学和管理。 项目1:B细胞存活和死亡的机制(Pelanda,R.) 项目1描述(由申请方提供):每天产生数百万个表达自身反应性抗体的B细胞。最近在小鼠中的研究表明,与骨髓中的自身抗原反应的新生成的未成熟B细胞经历受体编辑和无反应性,并且受体编辑有助于外周保护性抗体库的显著部分。这些最近的研究还表明,克隆删除,一度被认为是中枢耐受的主要机制,可能是一个默认的途径,进行时,自身反应性B细胞不能编辑其受体。该模型固有的是,自身反应性B细胞必须存活一定的时间以成功编辑其受体。自身反应性和非自身反应性未成熟B细胞的细胞存活差异最终控制这些细胞的选择并形成外周B细胞库。因此,我们提出,自身反应性未成熟B细胞的存活窗口,在此期间发生受体编辑是绝对必要的保护性外周抗体库的发展。在受体编辑过程中,生理学上控制未成熟B细胞寿命的因素尚不清楚,尽管可能涉及抗凋亡和促凋亡途径的调节活性。除了受体编辑之外,特异性、有效和无害的B细胞库的产生还依赖于在非自身反应性BCR表达时停止进一步的IG基因重排并介导免疫球蛋白等位基因/同种型排斥的信号。这些途径的功能障碍可能导致过度克隆缺失,导致免疫缺陷或自身反应性B细胞存活,导致自身免疫。 现有证据表明,非自身反应性B细胞抗原受体的表达会产生紧张信号,这些信号对于非自身反应性(原代和编辑的以及可能无反应性)未成熟B细胞的生存以及免疫球蛋白等位基因/同种型排斥非常重要。我们建议,NF-?B通路、BAFF-R信号传导和Bcl-2家族正确翻译B细胞抗原受体信号传导以调节细胞寿命和免疫球蛋白基因重组。我们已经建立了产生非自身反应性或自身反应性未成熟B细胞的小鼠品系,以及具有异常水平的BCR和BAFF-R表达的其他品系。使用这些生物学工具,我们建议,以确定如何NF-?B通路和Bcl-2家族调节原代未成熟B细胞的寿命,以及BCR和BAFF-R信号传导对细胞存活和建立IG等位基因/同种型排斥的相对贡献。 这个项目将有助于我们理解是什么调节发育中的B细胞的寿命,特别是取决于细胞是否具有自身反应性。此外,我们的研究结果将表明自身反应性B细胞逃避耐受并最终分化为自身抗体形成细胞的可能机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Philippa C. Marrack其他文献

Philippa C. Marrack的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Philippa C. Marrack', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    8311797
  • 财政年份:
    2011
  • 资助金额:
    $ 2.13万
  • 项目类别:
Functions of Bcl-2 Related Proteins in Activated T Cell Death
Bcl-2相关蛋白在活化T细胞死亡中的功能
  • 批准号:
    8311793
  • 财政年份:
    2011
  • 资助金额:
    $ 2.13万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7694126
  • 财政年份:
    2008
  • 资助金额:
    $ 2.13万
  • 项目类别:
Functions of Bcl-2 Related Proteins in Activated T Cell Death
Bcl-2相关蛋白在活化T细胞死亡中的功能
  • 批准号:
    7663282
  • 财政年份:
    2008
  • 资助金额:
    $ 2.13万
  • 项目类别:
Administrative
行政的
  • 批准号:
    7188255
  • 财政年份:
    2007
  • 资助金额:
    $ 2.13万
  • 项目类别:
Functions of Bcl-2 Related Proteins in Activated T Cell Death
Bcl-2相关蛋白在活化T细胞死亡中的功能
  • 批准号:
    7188251
  • 财政年份:
    2006
  • 资助金额:
    $ 2.13万
  • 项目类别:
AMID in Apoptosis and p53-Mediated Downstream Effects
AMID 在细胞凋亡和 p53 介导的下游效应中的作用
  • 批准号:
    7092608
  • 财政年份:
    2004
  • 资助金额:
    $ 2.13万
  • 项目类别:
AMID in Apoptosis and p53-Mediated Downstream Effects
AMID 在细胞凋亡和 p53 介导的下游效应中的作用
  • 批准号:
    7227149
  • 财政年份:
    2004
  • 资助金额:
    $ 2.13万
  • 项目类别:
AMID in Apoptosis and p53-Mediated Downstream Effects
AMID 在细胞凋亡和 p53 介导的下游效应中的作用
  • 批准号:
    7908140
  • 财政年份:
    2004
  • 资助金额:
    $ 2.13万
  • 项目类别:
AMID in Apoptosis and p53-Mediated Downstream Effects
AMID 在细胞凋亡和 p53 介导的下游效应中的作用
  • 批准号:
    7408606
  • 财政年份:
    2004
  • 资助金额:
    $ 2.13万
  • 项目类别:

相似国自然基金

基于Recognition-VR 虚拟现实的“家庭-社区-医院三向联动”轻度认知障碍防治模式研究
  • 批准号:
    2021JJ60094
  • 批准年份:
    2021
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Unrestricted antigen recognition by T lymphocytes
T 淋巴细胞不受限制的抗原识别
  • 批准号:
    DP170104386
  • 财政年份:
    2017
  • 资助金额:
    $ 2.13万
  • 项目类别:
    Discovery Projects
Real-time Measurement of Self-antigen Recognition by Lymphocytes In Vivo
体内淋巴细胞自身抗原识别的实时测量
  • 批准号:
    8191110
  • 财政年份:
    2011
  • 资助金额:
    $ 2.13万
  • 项目类别:
Real-time Measurement of Self-antigen Recognition by Lymphocytes In Vivo
体内淋巴细胞自身抗原识别的实时测量
  • 批准号:
    8263743
  • 财政年份:
    2011
  • 资助金额:
    $ 2.13万
  • 项目类别:
The antigen recognition mechanism by dual receptors of cytotoxic T lymphocytes
细胞毒性T淋巴细胞双受体的抗原识别机制
  • 批准号:
    14570283
  • 财政年份:
    2002
  • 资助金额:
    $ 2.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Antigen Recognition by Lymphocytes
淋巴细胞识别抗原
  • 批准号:
    7663286
  • 财政年份:
    1997
  • 资助金额:
    $ 2.13万
  • 项目类别:
Antigen Recognition by Lymphocytes
淋巴细胞识别抗原
  • 批准号:
    7929677
  • 财政年份:
    1997
  • 资助金额:
    $ 2.13万
  • 项目类别:
Antigen Recognition by Lymphocytes
淋巴细胞识别抗原
  • 批准号:
    7187865
  • 财政年份:
    1997
  • 资助金额:
    $ 2.13万
  • 项目类别:
Antigen Recognition by Lymphocytes
淋巴细胞识别抗原
  • 批准号:
    7483029
  • 财政年份:
    1997
  • 资助金额:
    $ 2.13万
  • 项目类别:
Antigen Recognition by Lymphocytes
淋巴细胞识别抗原
  • 批准号:
    8134395
  • 财政年份:
    1997
  • 资助金额:
    $ 2.13万
  • 项目类别:
ANTIGEN RECOGNITION BY LYMPHOCYTES
淋巴细胞对抗原的识别
  • 批准号:
    6627969
  • 财政年份:
    1985
  • 资助金额:
    $ 2.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了